Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

7.79
-0.0200-0.26%
Post-market: 7.790.00000.00%19:05 EST
Volume:133.31K
Turnover:1.04M
Market Cap:291.86M
PE:-6.11
High:7.93
Open:7.86
Low:7.76
Close:7.81
52wk High:8.85
52wk Low:4.76
Shares:37.47M
Float Shares:19.02M
Volume Ratio:1.00
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2740
EPS(LYR):-1.2740
ROE:-76.41%
ROA:-3.04%
PB:218.46
PE(LYR):-6.11

Loading ...

Lifecore files to sell $150M of common stock, warrants

TIPRANKS
·
Sep 23

BRIEF-Lifecore Biomedical Files For Mixed Shelf Of Up To $150 Million - SEC Filing

Reuters
·
Sep 23

Lifecore Biomedical Inc Files for Mixed Shelf of up to$150 Mln - SEC Filing

THOMSON REUTERS
·
Sep 23

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

GlobeNewswire
·
Sep 05

KeyBanc Initiates Lifecore Biomedical at Sector Weight

MT Newswires Live
·
Sep 04

Lifecore Biomedical Initiated at Sector Weight by Keybanc

Dow Jones
·
Sep 04

U.S. RESEARCH ROUNDUP-Alphabet, Copart, Leidos

Reuters
·
Sep 04

Lifecore Biomedical Inc : Keybanc Initiates Coverage With Sector Weight Rating

THOMSON REUTERS
·
Sep 04

Lifecore Biomedical to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 03

Lifecore Biomedical Inc. Appoints KPMG as New Auditor Amid Internal Control Weakness Concerns

Reuters
·
Aug 19

Lifecore Biomedical Q4 EPS $(0.06) Beats $(0.10) Estimate, Sales $36.444M Beat $35.363M Estimate

Benzinga
·
Aug 08

Lifecore Biomedical Inc - Expects $74-$76 Mln Revenue for Remainder of 2025

THOMSON REUTERS
·
Aug 08

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Aug 08

Lifecore Biomedical Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Aug 06

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

GlobeNewswire
·
Aug 01

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 18

Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer

MT Newswires Live
·
Jun 17

Press Release: Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

Dow Jones
·
Jun 12

Aron R. English, 10% Owner, Reports Disposal of Lifecore Biomedical Inc. Common Shares

Reuters
·
May 29

Press Release: Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Dow Jones
·
May 27